Eiger BioPharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 51-72 of 72 matching filings.

Per page
25
Current page
3
SC 13G/A File 005-87931

SCHEDULE 13G AMENDMENT

Filing date
04 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

CELLADON CORP

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A filing

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SCHEDULE 13G AMENDMENT

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
29 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
07 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SCHEDULE 13G/A

Filing date
05 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
24 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G filing

Filing date
30 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

CELLADON CORPORATION

Filing date
11 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A filing

Filing date
08 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SCHEDULE 13G AMENDMENT

Filing date
20 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
27 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SCHEDULE 13G

Filing date
06 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

LUNDBECKFOND A/S

Filing date
23 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
18 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
10 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

CELLADON CORPORATION

Filing date
07 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SCHEDULE 13G

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
12 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
12 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .